Search research articles
Contact Us
Filters
Showing results (471-480 of 571) with videos related to
Page
of 58
Sort By:
Stem Cell Research & Therapy
|
August 31, 2015
Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities
Xiao-Ming Wang, Wing Yan Yik, Peilin Zhang, et al.
Environmental Technology
|
March 7, 2024
Integrating reverse osmosis to a conventional river water treatment plant as a strategy to produce drinking water after mining dam rupture events: a case study
Victor Rezende Moreira, Priscila B Moser, Roberta N Guimarães, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Carlee B Moser, Kara W Chew, Justin Ritz, et al.
Nature
|
August 29, 1996
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
E Oberlin, A Amara, F Bachelerie, et al.
The Journal of Experimental Medicine
|
December 1, 1996
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors
A Granelli-Piperno, B Moser, M Pope, et al.
Open Forum Infectious Diseases
|
February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy
Thomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
JAMA Neurology
|
March 14, 2017
Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy
Bela R Turk, Benjamin E Theisen, Christina L Nemeth, et al.
Molecular Genetics and Metabolism
|
January 12, 2016
Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines
Nancy E Braverman, Gerald V Raymond, William B Rizzo, et al.
The Journal of Experimental Medicine
|
June 24, 1998
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
K E Cole, C A Strick, T J Paradis, et al.
Molecular Genetics and Metabolism Reports
|
November 23, 2016
Diagnosis of a mild peroxisomal phenotype with next-generation sequencing
Meredith J Ventura, Dianna Wheaton, Mingchu Xu, et al.
Page
of 58
Search research articles
Search
Showing results (471-480 of 571) with videos related to
Sort By:
Page
of 58
Stem Cell Research & Therapy
|
August 31, 2015
Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities
Xiao-Ming Wang, Wing Yan Yik, Peilin Zhang, et al.
Environmental Technology
|
March 7, 2024
Integrating reverse osmosis to a conventional river water treatment plant as a strategy to produce drinking water after mining dam rupture events: a case study
Victor Rezende Moreira, Priscila B Moser, Roberta N Guimarães, et al.
The Journal of Infectious Diseases
|
August 31, 2023
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Carlee B Moser, Kara W Chew, Justin Ritz, et al.
Nature
|
August 29, 1996
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
E Oberlin, A Amara, F Bachelerie, et al.
The Journal of Experimental Medicine
|
December 1, 1996
Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors
A Granelli-Piperno, B Moser, M Pope, et al.
Open Forum Infectious Diseases
|
February 11, 2022
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy
Thomas A Premeaux, Carlee B Moser, Ashley McKhann, et al.
JAMA Neurology
|
March 14, 2017
Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy
Bela R Turk, Benjamin E Theisen, Christina L Nemeth, et al.
Molecular Genetics and Metabolism
|
January 12, 2016
Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines
Nancy E Braverman, Gerald V Raymond, William B Rizzo, et al.
The Journal of Experimental Medicine
|
June 24, 1998
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
K E Cole, C A Strick, T J Paradis, et al.
Molecular Genetics and Metabolism Reports
|
November 23, 2016
Diagnosis of a mild peroxisomal phenotype with next-generation sequencing
Meredith J Ventura, Dianna Wheaton, Mingchu Xu, et al.
Page
of 58